150 related articles for article (PubMed ID: 10083265)
1. Anergic cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplant Proc; 1999; 31(1-2):623. PubMed ID: 10083265
[No Abstract] [Full Text] [Related]
2. Anergic T cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
[TBL] [Abstract][Full Text] [Related]
3. IL-2 and IL-4 double knock-out mice reject islet allografts: a role for novel T-cell growth factors?
Roy-Chaudhury P; Manfro RC; Steiger J; Nickerson PW; Tian Y; Zheng XX; Li YS; Strom TB
Transplant Proc; 1997; 29(1-2):1083-4. PubMed ID: 9123210
[No Abstract] [Full Text] [Related]
4. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
Coulombe M; Lafferty KJ; Gill RG
Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
[No Abstract] [Full Text] [Related]
5. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody.
Rossini AA; Mordes JP; Markees TG; Phillips NE; Gordon EJ; Greiner DL
Transplant Proc; 1999; 31(1-2):629-32. PubMed ID: 10083269
[No Abstract] [Full Text] [Related]
6. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
[TBL] [Abstract][Full Text] [Related]
7. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment.
Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T
Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173
[No Abstract] [Full Text] [Related]
8. Dipeptide boronic acid, a novel proteasome inhibitor, prevents islet-allograft rejection.
Wu Y; Han B; Luo H; Shi G; Wu J
Transplantation; 2004 Aug; 78(3):360-6. PubMed ID: 15316363
[TBL] [Abstract][Full Text] [Related]
9. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
10. A protocol with FK 506 for inducing unresponsiveness to murine islet allografts.
Fukuzaki T; Gotoh M; Monden M; Dono K; Kanai T; Mori T
Surgery; 1995 Feb; 117(2):220-5. PubMed ID: 7531371
[TBL] [Abstract][Full Text] [Related]
11. The role of direct and indirect antigen presentation in the response to islet xenografts.
Gill RG
Transplant Proc; 1992 Apr; 24(2):642-3. PubMed ID: 1533075
[No Abstract] [Full Text] [Related]
12. Induction of tolerance to islet and skin allografts by intrathymic inoculation of thymic stromal cell clones in mice.
Koja S; Doi H; Satomi S; Fujimori K; Takemura M; Ohkohchi N; Miura S; Takeda Y; Morimoto K; Itoh T; Taguchi Y; Okazaki H
Transplant Proc; 1997; 29(1-2):765-6. PubMed ID: 9123516
[No Abstract] [Full Text] [Related]
13. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
[No Abstract] [Full Text] [Related]
14. Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts.
Jacobson S; Kumagai-Braesch M; Tibell A; Svensson M; Flodström-Tullberg M
Ann N Y Acad Sci; 2008 Dec; 1150():213-6. PubMed ID: 19120298
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
[No Abstract] [Full Text] [Related]
16. Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment.
Ohtsuka K; Yasunami Y; Ikehara Y; Nagai T; Kodama S; Maki T; Tomita A; Abo T; Ikeda S
Transplantation; 1997 Aug; 64(4):633-9. PubMed ID: 9293878
[TBL] [Abstract][Full Text] [Related]
17. Rejection of human islet allografts in human lymphocyte-reconstituted severe combined immunodeficient mice.
Shiroki R; Poindexter NJ; Mohanakumar T; Scharp DW
Transplant Proc; 1994 Apr; 26(2):716-7. PubMed ID: 8171622
[No Abstract] [Full Text] [Related]
18. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice.
Song HK; Alters SE; Fathman CG
Transplantation; 1993 Jan; 55(1):133-9. PubMed ID: 8420037
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
[No Abstract] [Full Text] [Related]
20. A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection.
Waegell W; Babineau M; Hart M; Dixon K; McRae B; Wallace C; Leach M; Ratnofsky S; Belanger A; Hirst G; Rossini A; Appel M; Mordes J; Greiner D; Banerjee S
Transplant Proc; 2002 Aug; 34(5):1411-7. PubMed ID: 12176420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
